Mestag Therapeutics ("Mestag"), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded ...

CAMBRIDGE, United Kingdom, Nov. 13, 2024 (GLOBE NEWSWIRE ... in solid tumors and their role in driving improved patient outcomes; the M402 program, targeting a stromal checkpoint to dampen down the ...

Radiotherapy-activated NBTXR3 is being evaluated across multiple solid tumor indications as a single agent or in combination with anti-PD-1 immune checkpoint inhibitors ... The Company has ...

Added expert industry leaders to Supervisory Board, further strengthening support for the Company’s long-term growth strategy NBTXR3 program update from pancreatic cancer study and lung cancer study ...

CAMBRIDGE, UK I November 11, 2024 I STORM Therapeutics Ltd ... Additional preclinical studies have demonstrated enhanced anti-tumor properties in combination with checkpoint inhibitors, supporting ...

Pampers Private School (PPS) has announced the relocation of her Lekki campus to a new and modern facility, designed to enhance ...

Bicycle Therapeutics is a biopharma company targeting unmet medical needs. Discover why BCYC stock benefits from strong ...

Mr. Olalekan Oluwadairo, Head of School at Pampers Private School, Lekki, explained that the new Lekki campus features modern classrooms equipped with the required technology, conducive learning ...

Check Point met analyst expectations in the third quarter of 2024 but failed to excite investors. Investors hoped for Check Point to gain from CrowdStrike's expensive July outage, but results didn ...

Check Point Software (NASDAQ:CHKP) plunged 14% during early market action Tuesday following its third quarter 2024 financial results, which were released pre-market. For the quarter ended ...